Tianjin Development Unit Lisheng Pharma Posts Sharp Interim Profit DeclineTip Ranks·Aug 20 at 05:37 PM00882-0.72%002393+0.42%
Tianjin Lisheng Pharma, Tianjin Development Holdings subsidiary, posts H1 net profit RMB 80.08 millionPUBT·Aug 20 at 05:20 PM00882-0.72%002393+0.42%
Tianjin Development Holdings sets board meeting to review interim resultsPUBT·Aug 17 at 04:37 AM00882-0.72%
Tianjin Development Holdings files board, committee and management disclosure rosterPUBT·Jul 31 at 04:50 AM00882-0.72%
Tianjin Development Flags Sharp Profit Drop at Lisheng Pharmaceutical for H1 2026Tip Ranks·Jul 14 at 05:37 PM00882-0.72%002393+0.42%
Tianjin Development affiliate Lisheng Pharmaceutical invests RMB 180 million in Industrial Bank wealth productsPUBT·Jun 25 at 05:32 AM601166-3.00%00882-0.72%
Tianjin Development Wins Strong Shareholder Backing at 2026 AGMTip Ranks·Jun 23 at 06:17 AM00882-0.72%
Tianjin Development Holdings AGM backs final dividend of HK 0.0882 a sharePUBT·Jun 23 at 05:35 AM00882-0.72%
Tianjin Development director Wong faces SFC court action over Target Insurance delistingPUBT·Jun 18 at 05:33 AM00882-0.72%
Tianjin Development Secures HK$100 Million Revolving Loan Tied to State Majority ControlTip Ranks·Apr 29 at 07:46 AM00882-0.72%
"Performance" Tianjin Development's annual net profit is 428 million yuan, down 21.9%, with a final dividend of 8.82 centsAASTOCKS·Mar 30 at 09:01 AM00882-0.72%
Tianjin Development Holds Dividend Steady as Recurring Profit Rises Despite Lower Headline EarningsTip Ranks·Mar 30 at 07:53 AM561700-0.36%00882-0.72%
Tianjin Development's subsidiary Lishengpharma A's annual net profit increased by 125.6% to 416 million RMB, with a dividend of 60 cents RMBAASTOCKS·Mar 24 at 07:25 PM159892-0.72%520880-0.84%
Tianjin Development’s Pharma Unit Lisheng Posts Profit Surge and Proposes DividendTip Ranks·Mar 24 at 05:43 PM002393+0.42%00882-0.72%
